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Research
Ozone is an oxidant gas that is an important
component of urban air pollution. It is
generated from oxygen by photochemical
reactions involving oxides of nitrogen and
hydrocarbons produced by combustion.
Environmental O3 standards and guidelines
include those of the World Health
Organization (WHO 2000) and European
Union (European Communities 2002), 120
µg/m3 (0.06 ppm); and U.S. Environmental
Protection Agency (U.S. EPA 2004), 0.08
ppm (167 µg/m3)—each as an average for an
8-hr period. These levels are exceeded in some
regions; in Europe, O3 levels routinely
exceeded 0.1 ppm during the summer of 2003
(Fiala et al. 2003), and in Mexico City 1-hr
averages were as high as 0.102 ppm (Romieu
et al. 2004).
The acute respiratory health effects of
short-term exposures to O3 have been well
characterized through controlled human expo-
sure studies of healthy subjects using O3 con-
centrations from 0.2 to 0.6 ppm (Aris et al.
1993; Balmes et al. 1996; Koren et al. 1989;
Seltzer et al. 1986). Single short-term expo-
sures are known to cause acute changes in pul-
monary function, such as increased specific
airways resistance (SRaw) and decreased forced
expiratory volume in 1 sec (FEV1) and forced
vital capacity (FVC) (Aris et al. 1993; Balmes
et al. 1996). In addition, indices of inﬂamma-
tion in respiratory tract lining ﬂuid (RTLF), as
measured in bronchoalveolar lavage (BAL) and
sputum induction (SI), are increased by short-
term exposures. The inflammatory response
most consistently seen includes an increase in
neutrophils (Aris et al. 1993; Koren et al.
1989; Seltzer et al. 1986). Other markers of
inﬂammation that also are increased after O3
exposure include ﬁbronectin, total protein, and
cytokines such as interleukin (IL)-6 and IL-8
(Balmes et al. 1996; Koren et al. 1989).
The respiratory health effects of multiday
exposure are not as well studied. Pulmonary
function decrements are known to attenuate
on the third and fourth day of multiday expo-
sures (Christian et al. 1998; Hackney et al.
1977). It is less clear how injury and inﬂam-
mation are affected by multiday exposures. A
study from our laboratory showed attenuation
of the inflammatory response in BAL in
healthy subjects exposed to 0.2 ppm O3 for
4 hr on 4 consecutive days compared with a
single-day exposure (Christian et al. 1998). A
similar study by Jorres et al. (2000) used both
BAL and endobronchial biopsies to assess air-
way inflammation. BAL fluid showed an
increase in neutrophils after the single-day but
not after the 4-day exposure. IL-6, IL-8, and
total protein were increased after both expo-
sure arms in the BAL ﬂuid. The endobronchial
biopsies, representing proximal airways,
showed increased neutrophils after the 4-day
exposure but not after the single-day exposure.
SI is less invasive and less technically difﬁ-
cult than bronchoscopy and has been used to
obtain RTLF to assess airway inflammation
after O3 exposure (Fahy et al. 1995; Hiltermann
et al. 1995). It is not clear that samples of RTLF
obtained by SI and BAL are interchangeable for
measuring O3-induced airway inflammation
(Arjomandi et al. 2005). SI and BAL may be
primarily sampling different compartments of
the airway, more proximal for SI and more dis-
tal for BAL (Alexis et al. 2001). Also, data from
induced sputum may be more inherently vari-
able than are data from BAL, making it more
difficult to detect O3-induced inflammation
(Arjomandi et al. 2005).
In this study we used SI to sample RTLF
after single- and multiday exposures to assess
the effect of repeated exposures to O3 on
proximal airways. Our hypothesis was that
neutrophils in induced sputum would increase
as a function of multiday exposure compared
with single-day exposure.
Materials and Methods
Design. In this study we used a two-condition,
single-blind, randomized, crossover design.
Subjects completed an initial characterization
session and subsequently two exposure condi-
tions: exposure to O3 (0.2 ppm) for 4 hr for
1 day (1D) and exposure to O3 (0.2 ppm) for
4 hr for 4 consecutive days (4D; days 1–4:
4D-1, 4D-2, 4D-3, 4D-4). To assess airway
inflammation, we conducted SI 18 hr after
the exposure in the 1D condition and 18 hr
after the fourth exposure of the 4D condition.
We assessed lung function response by
spirometry and by measuring airway resistance
preexposure, postexposure, and pre-SI. The
two exposure conditions were separated by a
minimum of 3 weeks.
Subjects. Fifteen healthy nonsmoking sub-
jects (seven male, eight female; mean ± SD
age = 24 ± 2.9 years) participated. The study
protocol was approved by the Committee
on Human Research of the University of
California San Francisco; all applicable
requirements for ethical human research were
met; all subjects gave written informed consent
before enrollment. Subjects completed a med-
ical history questionnaire and were character-
ized by physical, spirometric, and nonspeciﬁc
airway reactivity measurements (Table 1).
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Subjects had no previous or current lung
disease or other serious disease.
Pulmonary function. We performed
spirometry using a rolling seal spirometer (Ohio
840, Ohio Medical, Dayton, OH) according to
criteria of the American Thoracic Society
(American Thoracic Society 1987). SRaw was
calculated as the mean of ﬁve measurements of
airway resistance and thoracic gas volume in a
constant-volume variable-pressure whole-body
plethysmograph (Warren E. Collins Inc.,
Braintree, MA) measured every 30 sec for
2.5 min. We conducted spirometry and
plethysmography for subject characterization,
immediately pre- and postexposure, and pre-SI.
Nonspeciﬁc airway reactivity. For subject
characterization, we determined nonspeciﬁc air-
way reactivity using increasing doses of metha-
choline to observe a 20% decrease in FEV1.
Exposure. We conducted all exposures with
the subject in a stainless steel and glass chamber
(8 × 8 × 8 ft) to control for environmental air
temperature and humidity. The chamber air
supply was passed through two ﬁlters in series, a
charcoal ﬁlter and a Puraﬁl ﬁlter (Puraﬁl Inc.,
Atlanta, GA), and chamber temperature and
relative humidity were continuously monitored.
O3 was generated by passing 100% oxygen
through an ozonator (Welsbach no. T-408;
Ozone Engineering, El Sobrante, CA), and the
concentration was targeted to 0.2 ppm as meas-
ured by an ultraviolet O3 analyzer (model 1003;
Dasibi Environmental Corp., Glendale, CA).
O3 exposures were conducted using a mouth-
breathing facemask (Hans Rudolph Inc., Kansas
City, MO) ﬁtted with a nonrebreathing valve
(Hans Rudolph 2600). There were no signiﬁ-
cant differences between any of the exposure
conditions, O3 concentration, temperature, and
relative humidity, between the 1D and 4D 
conditions and within the 4D condition
(Table 2). Exposures were of 4-hr duration.
Exercise. During the exposure, subjects
performed intermittent exercise (30 min of
each 60 min) on a cycle ergometer (Corvial
400; Quinton Instruments Co., Seattle, WA).
The work level selected was based on the
workload required to achieve and maintain a
calculated minute ventilation of 25 L/min ×
body surface area. During each 30-min exer-
cise period, minute ventilation was measured
at 10 and 20 min using a section of corrugated
tubing placed between the valve on the face-
mask and a Fleisch pneumotachograph
(General Medical Corp., West Sacramento,
CA); flow signals recorded from the pneu-
motachograph were amplified (Validyne
Engineering Corp., Northridge, CA) to yield
volume signals and then recorded on a visi-
corder (Honeywell 1858; Honeywell Test
Instruments Division, Denver, CO). There
was a statistically signiﬁcant decrease of minute
ventilation in 4D-4 compared with both 1D
and 4D-1 [median (25–75% range); 46.3
(42.0–51.4) L/min vs. 48.3 (45.0–53.8) L/min
and 48.6 (43.0–57.8) L/min; p = 0.029 and
p = 0.031, respectively]. There were no other
significant differences between conditions or
within the 4D condition.
Sputum induction. All subjects were pre-
treated with 180 µg albuterol administered by
metered-dose inhaler and then inhaled nebu-
lized sterile 3% saline for 20 min from an
ultrasonic nebulizer [DeVilbiss Ultra-Neb 99;
DeVilbiss Air Power Co., Jackson, TN; this
nebulizer generates particles of a mean mass
median diameter of 3.5 µm and has an output
of 5.9 mL/min]. Subjects were encouraged to
cough airway secretions into a plastic container
throughout the procedure. At 4-min intervals,
subjects were instructed to cough airway secre-
tions and saliva into the plastic container, and
a peak ﬂow measurement was obtained. SI was
performed 18 hr postexposure.
Sputum processing. The volume of the
induced sputum sample was determined and
then mixed with an equal volume of 0.1%
dithiothreitol (Sputalysin 10%; Behring
Diagnostics Inc., Somerville, NJ) for homoge-
nization. The sample was then mixed gently by
Table 1. Individual subject characteristics.
Age Height FEV1 FVC SRaw PC20
Subject Sex (years) (cm) Liter % predicted Liter % predicted (cm H2O/L/sec) (mg/mL)
01 M 31 167 3.45 91 3.90 83 6.9 > 64
02 F 20 153 3.65 125 4.05 113 4.4 > 64
03 M 24 180 5.45 123 6.30 114 5.3 > 64
04 M 27 174 4.20 100 5.20 99 6.7 > 64
05 F 23 167 3.90 117 4.15 100 3.9 10.72
06 M 23 189 5.70 118 7.00 113 5.9 14.59
07 F 27 168 3.35 102 3.85 94 5.0 > 80
08 F 26 168 3.55 108 4.35 105 5.4 5.61
09 F 22 168 3.55 105 4.00 95 3.5 15.27
10 F 25 171 3.90 113 5.40 125 5.9 > 80
11 M 28 186 4.70 103 7.75 132 7.1 4.66
12 F 23 173 3.75 106 4.15 94 5.1 12.6
13 F 22 166 4.25 127 5.25 127 6.0 > 80
14 M 22 187 5.45 113 6.25 102 5.1 10.50
15 M 24 185 5.55 119 6.95 117 5.9 > 80
Mean 7 M 24.5 173.3 4.29 111 5.24 108 5.48 NA
8 F
SD 2.9 10.0 0.85 10.2 1.32 14.0 1.05 NA
Abbreviations: F, female; M, male; NA, not applicable; PC20, provocative concentration of methacholine producing a
> 20% decrease in FEV1.
Table 2. Exposure characteristics (mean ± SD).
Exposure characteristic 1-day exposure 4-day exposure
O3 (ppm) 0.201 ± 0.008 0.204 ± 0.09
Temperature (°C) 19.9 ± 0.29 19.8 ± 0.31
Relative humidity (%) 52.0 ± 4.26 51.2 ± 4.84
Table 3. Cell and protein analyses of induced sputum 18 hr after 1D and 4D exposure to O3 [median
(25–75% range)].
Analyte 1D 4D
Total leukocytes (cells × 104/mL) 42.7 (23.2–60.6) 45.8 (31.3–71.0)
Neutrophils (%) 56.7 (52.2–74.1) 72.5 (66.3–79.7)*
Macrophages (%) 40.7 (25.4–43.0) 27.0 (18.5–31.9)**
Lymphocytes (%) 1.3 (0.8–4.2) 1.8 (0.2–2.3)
Eosinophils (%) 0.0 (0.0–0.8) 0.0 (0.0–1.2)
Total protein (mg/mL) 908 (624–1,016) 872 (583–976)
LDH (U/L) 78 (64–123) 90 (63–118)
Fibrinogen (ng/mL) 982 (439–2,478) 1,567 (441–3,213)
IL-6 (pg/mL) 73 (15–106) 42 (27–105)
IL-8 (pg/mL) 2,936 (738–7,025) 2,972 (937–4,228)
*p = 0.02 versus 1D neutrophils (%) (Wilcoxon signed rank test); **p = 0.027 versus 1D macrophages (%) (Wilcoxon signed
rank test).
Figure 1. Individual data and group median values for
neutrophil percentage for the 1D and 4D conditions.
*p = 0.02 versus 1D neutrophils (%) (Wilcoxon signed-
rank test).
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*vortex mixer and placed in a shaking water
bath at 37°C for 15 min to ensure complete
homogenization. The sample was removed
from the water bath periodically for further
brief gentle vortex mixing. One milliliter of the
homogenized sputum sample was aliquoted for
cell counts, and the remainder of the sample
was centrifuged at 1,037 × g for 5 min. The
supernatant was aspirated and stored at –70°C
for subsequent protein analysis.
Cell counts. Ten microliters of homoge-
nized induced sputum was used to determine
the total leukocyte count using a standard
hemacytometer. For cell differentiation,
250-µL aliquots of homogenized induced spu-
tum were spun in a cytocentrifuge (model 7
Cytospin; Shandon Scientiﬁc, Pittsburgh, PA)
onto glass slides that were then stained (May
Grunwald Giemsa stain). Differential cell
counts included macrophages, lymphocytes,
neutrophils, and eosinophils (each expressed as
a percentage of total leukocytes). One investi-
gator, blinded to the subject’s exposure condi-
tion, counted at least 400 cells.
Protein assays. We measured total protein
using the Bradford method, with reagents from
Bio-Rad Laboratories (Hercules, CA). Lactate
dehydrogenase (LDH) was measured using a
spectrophotometer and a LDH reagent (LD-L;
Sigma-Aldrich, St. Louis, MO). Fibrinogen
was measured by enyzme-linked immuno-
sorbent assay (ELISA) with reagents from
Sigma-Aldrich. IL-6 and IL-8 levels were meas-
ured using immunoassays (ELISA, Quantikine;
R&D Systems, Minneapolis, MN) with lower
limits of detection of 0.09 and 18.0 pg/mL,
respectively. Detailed descriptions of our meth-
ods for fluid-phase measurements of soluble
proteins in induced sputum have been pub-
lished previously (Fahy et al. 1993).
Symptoms. The symptom score was based
on a questionnaire with a 5-point scale [0 (not
noticeable), 1 (minimal), 2 (mild), 3 (moder-
ate), and 4 (severe)] administered immediately
before and after exposure. Symptoms rated
were chest discomfort, chest pressure, cough,
sputum production, shortness of breath, and
wheezing.
Statistical analysis. We compared data
from the exposure environments (O3 concen-
tration, temperature, humidity) using the
paired t-test. Because most of the data for the
dependent variables (cell counts, protein con-
centrations, spirometry) did not ﬁt a normal
distribution, both within- and between-
condition paired comparisons were conducted
using the Wilcoxon signed rank test. We con-
sidered a p-value of < 0.05 significant. Post
hoc power calculations indicated that the sam-
ple size of 15 provided 0.78 power at α = 0.10
and 0.66 power at α = 0.05 to detect the
observed difference in neutrophils between the
1D and 4D conditions.
Results
Cells and proteins. For the cell data, we com-
pared the 4D condition with the 1D condition
and found a signiﬁcant increase in the percent-
age of neutrophils and a signiﬁcant decrease in
the percentage of macrophages (Table 3;
Figure 1). There were no other signiﬁcant dif-
ferences in any other cell percentages. We also
found no signiﬁcant differences for total pro-
tein concentration, LDH, ﬁbrinogen, IL-6, or
IL-8 when we compared the 1D condition
with the 4D condition (Table 3).
Pulmonary function. There were some
small but statistically signiﬁcant differences in
preexposure values for FEV1 and FVC between
the 1D and 4D conditions and within the 4D
condition (Figure 2). There were no statisti-
cally signiﬁcant differences in the values for the
preexposure SRaw either between the condi-
tions or within the 4D condition (Figure 2).
For FEV1 and FVC there were significant
decreases from preexposure to postexposure in
the 1D condition (Figure 2). FEV1 and FVC
also decreased signiﬁcantly on 4D-1 and 4D-2
(Figure 2). 4D-3 FVC had a significant
decrease and 4D-3 FEV1 had a decrease that
was not signiﬁcant (Figure 2). The difference
from preexposure to postexposure was not
statistically significant for either FEV1 or
FVC on 4D-4 (Figure 2). Comparing the pre-
exposure SRaw with postexposure measurement,
we observed statistically signiﬁcant increases for
1D and for 4D-2 and 4D-3 (Figure 2).
Symptoms. Symptom ratings had no signiﬁ-
cant difference for the preexposure values
between conditions or within the 4D condition.
The difference between the preexposure and
postexposure score was signiﬁcant for the 1D
condition, and all 4 days of the 4D condition.
The symptom change decreased from 4D-2
through 4D-4 in the 4D condition. The change
in symptom rating [median (25–75% range)]
for the 1D exposure was 8 (3–11.5), and for the
4D exposure the changes were 5 (2–8) for
4D-1, 7 (5.5–10) for 4D-2, 3 (2–4) for 4D-3,
and 0 (0–1) for 4D-4. The 4D-2 change was
signiﬁcantly different from the 4D-3 and 4D-4
change, and the 4D-3 change was signiﬁcantly
different from the 4D-4 change.
Discussion
The results of this experiment conﬁrmed our
hypothesis that neutrophilic inflammation
would increase in induced sputum samples after
a multiday exposure to O3 compared with a
single-day exposure. Neutrophils were increased
as a percentage of total leukocytes in the multi-
day condition. Compared with a filtered air
exposure condition from a previous study (Fahy
et al. 1995), the neutrophil percentage (mean;
expressed as a percentage of nonsquamous cells)
was elevated in the 1D O3 condition, and to a
larger extent in the 4D O3 condition (ﬁltered
air, 51.0%; current 1D O3, 55.3%; current
4D, 69.8%). This indicates that our 1D expo-
sure to O3 caused neutrophil-associated inﬂam-
mation, with increased inflammation after
4 days of exposure. The macrophage percentage
was decreased with 4D exposure, although this
was mostly due to the increase in neutrophils.
There were no signiﬁcant changes in any of the
other measured cell and protein end points.
The symptom and pulmonary function
data followed a pattern seen in other multiday
Assessment of ozone-induced airway inflammation
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Figure 2. FEV1 (A), FVC (B), and SRaw (C) preexposure and postexposure values in the 1D and 4D (4D-1, 4D-2, 4D-3, 4D-4) O3 conditions. Values are median
(25–75% range). Abbreviations: Pre, preexposure; post, postexposure.
For FEV1: *signiﬁcant difference between preexposure and postexposure for 1D (p = 0.004), 4D-1 (p = 0.005), and 4D-2 (p = 0.001); **signiﬁcant difference for preexposure 1D compared
with both preexposure 4D-3 (p = 0.006) and preexposure 4D-4 (p = 0.004). For FVC: *signiﬁcant difference between preexposure and postexposure for 1D (p = 0.002) and 4D-1 (p = 0.004),
4D-2 (p = 0.001), and 4D-3 (p = 0.026); **signiﬁcant difference for preexposure 4D-2 compared with both preexposure 4D-3 (p = 0.009) and preexposure 4D-4 (p = 0.049). For SRaw: *signiﬁ-
cant difference between preexposure and postexposure for 1D (p = 0.016) and on 4D-2 (p = 0.004) and 4D-3 (p = 0.006). All p-values are from Wilcoxon signed-rank test.
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)O3 exposure studies. The greatest changes in
pulmonary function values (decreases in FEV1
and FVC and an increase in SRaw) occurred on
day 2 of multiday exposure in both the present
and previous studies (Hackney et al. 1977;
Christian et al. 1998; Jorres et al. 2000). The
largest increase in respiratory symptoms also
occurred on the second day, in both the pres-
ent and previous studies (Christian et al.
1998). By day 4 of the multiday O3 exposure,
there was almost complete attenuation of
both the pulmonary function and symptom
responses to O3. However, preexposure FEV1
was signiﬁcantly lower on days 3 and 4 com-
pared with the preexposure value on day 1,
suggesting that full recovery from the effect of
the previous day’s exposure had not occurred.
The most surprising ﬁnding of the present
study is that there was no attenuation of the
neutrophil recruitment to the airways with the
multiday O3 exposure arm. This ﬁnding is in
contrast to those of previous studies by our
group and others in which attenuation of this
response using BAL to sample RTLF has been
observed (Devlin et al. 1997; Christian et al.
1998; Jorres et al. 2000). It is consistent, how-
ever, with the increased recruitment of neutro-
phils to proximal airway tissue demonstrated
in endobronchial biopsy samples after multi-
day exposure to O3 (Jorres et al. 2000). The
increased neutrophils that we observed after
multiday exposure to O3 in this study could be
due to multiple factors, but a differential
response between proximal and distal airway
compartments must be considered.
Although the evidence on which airway
compartments are sampled by SI is somewhat
conflicting, it is believed to sample proximal
airways preferentially compared with BAL,
which more preferentially samples distal airways
and alveoli (Alexis et al. 2001; Gershman et al.
1999). BAL samples only distinct segments of
the lung distal to the bronchus into which the
bronchoscope is wedged (Kelly et al. 1988). In
contrast, SI probably provides a more represen-
tative sample of proximal airways, although
with prolonged induction the distal parts can
also be sampled as evident from increased num-
bers of macrophages from the alveolar compart-
ment (Gershman et al. 1999; Holz et al. 1998).
Thus, it is interesting to note that after single
exposures to O3, both SI and BAL show
increased neutrophils, consistent with both
proximal and distal airway inflammatory
responses. Differences in BAL compared with
induced sputum in multiday studies could be
due to differences in the way O3 is absorbed by,
antioxidant defenses of, or the nature of the
inﬂammatory responses in proximal and distal
airway compartments, or the possibility that
neutrophils recruited to distal airways after O3
exposure migrate to more proximal airways.
Animal studies have shown differences in depo-
sition of O3 and subsequent airway injury
throughout the airways (Plopper et al. 1998).
Dose-dependent compartmental variations in
antioxidant enzyme activity have been demon-
strated in mice, rats, and rhesus monkeys
(Duan et al. 1996a, 1996b; Plopper et al.
1998). Differential O3 deposition or amount of
antioxidant enzymes present in various airway
compartments could also occur in humans.
This could lead to differences in the inﬂamma-
tory response to O3 in different regions of the
airway with multiday exposures, that is, attenu-
ation of neutrophil recruitment in distal areas
and increased recruitment in proximal areas.
Potential limitations of our study must be
considered. First, a ﬁltered-air exposure control
condition would have allowed direct determi-
nation of the independent effects of the 1D O3
and 4D O3 conditions. Second, the number of
subjects (n = 15) is a function of this being a
controlled human exposure study involving a
complicated protocol. A larger number of sub-
jects may have changed our results, although
multiple studies of the airway inflammatory
effects of O3 exposure have detected exposure-
related differences in airway inflammatory
responses with a similar sample size (Christian
et al. 1998; Fahy et al. 1995; Jorres et al.
2000). Third, the time point for sampling of
RTLF (18 hr postexposure) that we selected
could be questioned as not being at the peak of
O3-induced neutrophil recruitment (Schelegle
et al. 1991). We chose 18 hr postexposure for
RTLF sampling because inﬂammation is still
present and our laboratory has considerable
experience with analysis of samples obtained at
this time.
In conclusion, the major finding of this
study is the lack of attenuation of neutrophilic
inﬂammation in induced sputum samples after
a multiday exposure to O3 compared with a
single-day exposure. This result stands in
marked contrast to several studies, including
one from our group in which attenuation of
neutrophil recruitment was observed when
BAL was used to sample airway lining fluid.
These contrasting ﬁndings add to the body of
evidence that differential airway compartmen-
tal responses to O3 occur in humans and other
species. Such differential responses may have
importance for understanding the clinical
impact of ambient O3 exposures on susceptible
subgroups (e.g., persons with asthma). Thus,
further research on potential mechanisms
underlying compartmental responses to
O3-induced oxidative stress seems warranted.
REFERENCES
Alexis N, Hu S, Zeman K, Alter T, Bennett, W. 2001. Induced spu-
tum derives from the central airways: conﬁrmation using a
radiolabeled aerosol bolus delivery technique. Am J Respir
Crit Care Med 164:1964–1970.
American Thoracic Society. 1987. Standardization of spirome-
try—1987 update. Am Rev Respir Dis 126:1285–1298.
Aris R, Christian D, Hearne P, Kerr K, Finkbeiner W, Balmes J.
1993. Ozone-induced airway inﬂammation in human subjects
as determined by airway lavage and biopsy. Am Rev Respir
Dis 148:1363–1372.
Arjomandi M, Schmidlin I, Girling P, Ferrando R, Balmes J. 2005.
Sputum induction and bronchoscopy for assessment of
ozone-induced airway inflammation in asthma. Chest
128:416–423.
Balmes J, Chen L, Scannell C, Tager I, Christian D, Hearne P,
et al. 1996. Ozone-induced decrements in FEV1 and FVC do
not correlate with measures of inﬂammation. Am J Respir
Crit Care Med 153:904–909.
Christian D, Chen L, Scannell C, Ferrando R, Welch B, Balmes J.
1998. Ozone-induced inﬂammation is attenuated with multi-
day exposure. Am J Respir Crit Care Med 158:532–537.
Devlin R, Folinsbee L, Biscardi F, Hatch G, Becker S, Madden M,
etal. 1997. Inflammation and cell damage induced by repeated
exposure of humans to ozone. Inhal Toxicol 9:211–235.
Duan X, Buckpitt A, Pinkerton K, Ji C, Plopper C. 1996a. Ozone-
induced alterations in glutathione in lung subcompartments
of rats and monkeys. Am J Respir Cell Mol Biol 14:70–75.
Duan X, Plopper C, Brennan P, Buckpitt A. 1996b. Rates of glu-
tathione synthesis in lung subcompartments of mice and
monkeys: possible role in species and site selective injury.
J Pharmacol Exp Ther 277:1402–1409.
European Communities. 2002. Directive 2002/3/EC of the European
Parliament and of the Council of 12 February 2002 Relating to
Ozone in Ambient Air. Off J Eur Commun L67:14–30. 
Fahy J, Liu J, Wong H, Boushey H. 1993. Cellular and biochemical
analysis of induced sputum from asthmatic and from healthy
subjects. Am Rev Respir Dis 147:1126–1131.
Fahy J, Wong H, Liu J, Boushey H. 1995. Analysis of induced spu-
tum after air and ozone exposures in healthy subjects.
Environ Res 70:77–83.
Fiala J, Cernikovsky L, Leeuw F, Kurfuerst P. 2003. Air pollution by
ozone in summer 2003. Topic Report. European Topic Centre
on Air and Climate Change. Copenhagen:European
Environmental Agency.
Gershman N, Liu H, Wong H, Liu J, Fahy J. 1999. Fractional analy-
sis of sequential induced sputum samples during sputum
induction: evidence that different lung compartments are
sampled at different time points. J Allergy Clin Immunol
104:322–328.
Hackney J, Linn W, Mohler J, Collier C. 1977. Adaptation to short-
term respiratory effects of ozone in men exposed repeatedly.
J Appl Physiol 43:82–85.
Hiltermann T, Stolk J, Hiemstra P, Fokkens P, Rombout P, Sont J,
et al. 1995. Effect of ozone exposure on maximal airway nar-
rowing in non-asthmatic and asthmatic subjects. Clin Sci
(Lond) 89:619–624.
Holz O, Jorres R, Koschyk S, Speckin P, Welker L, Magnussen H.
1998. Changes in sputum composition during sputum induction
in healthy and asthmatic subjects. Clin Exp Allergy 28:284–292.
Jorres R, Holz O, Zachgo W, Timm P, Koschyk S, Muller B, et al.
2000. The effect of repeated ozone exposures on inﬂamma-
tory markers in bronchoalveolar lavage ﬂuid and mucosal
biopsies. Am J Respir Crit Care Med 161:1855–1861.
Kelly C, Fenwick J, Corris P, Fleetwood A, Hendrick D, Walters E.
1988. Fluid dynamics during bronchoalveolar lavage. Am Rev
Respir Dis 138:81–84.
Koren H, Devlin R, Graham D, Mann R, McGee M, Horstman D,
et al. 1989. Ozone-induced inﬂammation in the lower airways
of human subjects. Am Rev Respir Dis 139:407–415.
Plopper C, Hatch G, Wong V, Duan X, Weir A, Tarkington B, et al.
1998. Relationship of inhaled ozone concentration to acute
tracheobronchial epithelial injury, site-speciﬁc ozone dose,
and glutathione depletion in rhesus monkeys. Am J Respir
Cell Mol Biol 19:387–399.
Romieu I, Sienra-Monge J, Ramirez-Aguilar M, Moreno-Macias
H, Reyes-Ruiz N, Estela del Rio-Navarro B, et al. 2004.
Genetic polymorphism of GSTM1 and antioxidant supple-
mentation inﬂuence lung function in relation to ozone expo-
sure in asthmatic children in Mexico City. Thorax 59:8–10.
Schelegle E, Siefkin A, McDonald R. 1991. Time course of ozone-
induced neutrophilia in normal humans. Am Rev Respir Dis
143:1353–1358.
Seltzer J, Bigby B, Stulbarg M, Holtzman M, Nadel J, Ueki I, et al.
1986. O3-induced change in bronchial reactivity to metha-
choline and airway inﬂammation in humans. J Appl Physiol
60:1321–1326.
U.S. EPA. 2004. EPA Green Book—8-Hour Ozone Area Standard.
Washington, DC:U.S. Environmental Protection Agency.
WHO. 2000. Air Quality Guidelines for Europe. World Health
Organization Regional Publications, European Ser No 91.
Copenhagen:World Health Organization.
Ratto et al.
212 VOLUME 114 | NUMBER 2 | February 2006 • Environmental Health Perspectives